Schedule 13G ownership disclosure
NEVRO CORP
Common Stock,$0.001 par value per share · CUSIP: 64157F103
Event date: 2025-03-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- THE GOLDMAN SACHS GROUP, INC.
Shares: 2,306,137.55 · Class: 6.0%
- GOLDMAN SACHS & CO. LLC
Shares: 2,306,137.55 · Class: 6.0%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000769993-25-000289
- Form type
- SCHEDULE 13G
- Filer
- GOLDMAN SACHS GROUP INC
- CIK
- CIK 886982
- Filed
- May 13, 2025
- Reporting period
- Mar 31, 2025
- Description
- Schedule 13G beneficial ownership